120 related articles for article (PubMed ID: 28799086)
1. Phase I and phase II metabolite identification of rutaecarpine in freshly isolated hepatocytes from male Sprague-Dawley rats.
Lee DW; Kang Y; Kang MJ; Noh K; Kim JH; Nepal MR; Shakya R; Lee YJ; Jahng Y; Lee S; Kim JA; Jeong TC
Arch Pharm Res; 2017 Aug; 40(8):972-979. PubMed ID: 28799086
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Phase II metabolites of rutaecarpine in rat by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Lee SK; Lee DW; Jeon TW; Jin CH; Kim GH; Jun IH; Lee DJ; Kim SI; Kim DH; Jahng Y; Jeong TC
Xenobiotica; 2005 Dec; 35(12):1135-45. PubMed ID: 16418066
[TBL] [Abstract][Full Text] [Related]
3. Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa.
Ueng YF; Yu HJ; Lee CH; Peng C; Jan WC; Ho LK; Chen CF; Don MJ
J Chromatogr A; 2005 May; 1076(1-2):103-9. PubMed ID: 15974075
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer.
Cai W; Guan Y; Zhou Y; Wang Y; Ji H; Liu Z
Pharm Biol; 2017 Dec; 55(1):294-298. PubMed ID: 27927077
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
6. Elimination of rutaecarpine and its metabolites in rat feces and urine measured by liquid chromatography.
Jan WC; Lin LC; Don MJ; Chen CF; Tsai TH
Biomed Chromatogr; 2006 Nov; 20(11):1163-71. PubMed ID: 16799925
[TBL] [Abstract][Full Text] [Related]
7. Induction of NAD(P)H: quinone reductase by rutaecarpine isolated from the fruits of Evodia rutaecarpa in the murine hepatic Hepa-1c1c7 cell line.
Ahn H; Nam JW; Seo EK; Mar W
Planta Med; 2008 Sep; 74(11):1387-90. PubMed ID: 18729042
[TBL] [Abstract][Full Text] [Related]
8. New glycosidic alkaloid from the nearly ripe fruits of Euodia rutaecarpa.
Hu CQ; Li KK; Yang XW
J Asian Nat Prod Res; 2012; 14(7):634-9. PubMed ID: 22582827
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Roongta V; Liu L; Moore DJ
Drug Metab Dispos; 2014 Jun; 42(6):1044-54. PubMed ID: 24696463
[TBL] [Abstract][Full Text] [Related]
11. Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation.
Xue H; Cheng Y; Wang X; Yue Y; Zhang W; Li X
J Pharm Biomed Anal; 2015 Nov; 115():307-14. PubMed ID: 26263059
[TBL] [Abstract][Full Text] [Related]
12. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
Tian KM; Li JJ; Xu SW
Pharmacol Res; 2019 Mar; 141():541-550. PubMed ID: 30616017
[TBL] [Abstract][Full Text] [Related]
13. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
Lee SK; Bista SR; Jeong H; Kim DH; Kang MJ; Jahng Y; Jeong TC
Arch Pharm Res; 2007 Dec; 30(12):1629-34. PubMed ID: 18254252
[TBL] [Abstract][Full Text] [Related]
14. Optimization of extraction of evodiamine and rutaecarpine from fruit of Evodia rutaecarpa using modified supercritical CO(2).
Liu B; Guo F; Chang Y; Jiang H; Wang Q
J Chromatogr A; 2010 Dec; 1217(50):7833-9. PubMed ID: 21067761
[TBL] [Abstract][Full Text] [Related]
15. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
16. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa.
Moon TC; Murakami M; Kudo I; Son KH; Kim HP; Kang SS; Chang HW
Inflamm Res; 1999 Dec; 48(12):621-5. PubMed ID: 10669112
[TBL] [Abstract][Full Text] [Related]
17. Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry.
Lee SK; Lee J; Lee ES; Jahng Y; Kim DH; Jeong TC
Rapid Commun Mass Spectrom; 2004; 18(10):1073-80. PubMed ID: 15150830
[TBL] [Abstract][Full Text] [Related]
18. Progress in the studies on rutaecarpine.
Lee SH; Son JK; Jeong BS; Jeong TC; Chang HW; Lee ES; Jahng Y
Molecules; 2008 Feb; 13(2):272-300. PubMed ID: 18305418
[TBL] [Abstract][Full Text] [Related]
19. [Optimization of a HPLC determination method for Evodia rutaecarpa].
Huang Z; Yi J; Wu Y; Liu Y; Chen Y; Liu Y
Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):478-80. PubMed ID: 21598546
[TBL] [Abstract][Full Text] [Related]
20. [Determination of evodiamine and rutaecarpine in Evodia rutaecarpa (Juss.) Benth after compatibility with Coptis chinensis Franch].
Xu YC; Wei LX; Zhou YX; Wang YL
Zhongguo Zhong Yao Za Zhi; 2001 Dec; 26(12):846-7. PubMed ID: 12776335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
